Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Prof. Dr. Ramasamy Paulmurugan is a globally recognized biomedical scientist and Professor of Radiology at Stanford University School of Medicine ๐Ÿ›๏ธ. With expertise in molecular imaging, nanomedicine, and gene therapy, his work focuses on cancer diagnostics and targeted therapeutics ๐ŸŽฏ๐Ÿงซ. He leads the Cellular Pathway Imaging Laboratory, developing cutting-edge biosensors and nanoparticle-based delivery systems ๐Ÿ’ก๐Ÿงช. Author of 145+ publications, he has received prestigious awards for innovation and research excellence ๐Ÿ…๐Ÿ“š. His interdisciplinary impact spans academia, clinical research, and biotechnology, making him a trailblazer in translational medicine and precision oncology ๐ŸŒโš•๏ธ.

Prof. Dr Ramasamy Paulmurugan, Stanford University, United States

Profile

SCOPUS

ORCID

GOOGLESCHOLAR

Education ย ๐ŸŽ“

Prof. Dr. Ramasamy Paulmurugan began his academic journey with a B.Sc. in Zoology, Botany, and Chemistry (1986โ€“1989) from Madurai Kamaraj University, India ๐Ÿธ๐ŸŒฟ๐Ÿงช. He pursued an M.Sc. in Biomedical Genetics (1989โ€“1991) at the University of Madras, developing a strong foundation in genetic science and human biology ๐Ÿงฌ๐Ÿง . He then earned a Ph.D. in Biomedical Genetics with specialization in Molecular Virology (1991โ€“1997) from National Environmental Engineering Research Institute and University of Madras, India ๐Ÿ”ฌ๐Ÿฆ . His education equipped him with the interdisciplinary knowledge and research skills essential for his impactful work in cancer biology and molecular medicine ๐Ÿ’กโš•๏ธ.

Honors & Awards ๐Ÿ…

Prof. Dr. Ramasamy Paulmurugan has received numerous prestigious awards throughout his career for outstanding contributions to biomedical science ๐Ÿงฌ๐Ÿง . His accolades include the Best Research Fellow Award (1991) from CSIR-NEERI ๐Ÿ‡ฎ๐Ÿ‡ณ, the Young Scientist Award (1999) from the Government of Kerala, and multiple Travel Awards from international imaging societies for best paper presentations in the USA and Germany โœˆ๏ธ๐Ÿ“„. He was honored with the Distinguished Investigator Award (2018) by the Academy for Radiology & Biomedical Imaging Research ๐Ÿงช and recently received the SAASCR Outstanding Achievement Award (2025) for advancing Asian American cancer research ๐ŸŒ๐Ÿ”ฌ.

Experience ย ๐Ÿฅ

Prof. Dr. Ramasamy Paulmurugan has over three decades of research and academic experience across India and the United States ๐ŸŒ. He began as a Junior and Senior Research Fellow in Molecular Virology in India (1991โ€“1996) ๐Ÿ”ฌ, later leading the Environmental Biotechnology Division at RGCB as Scientist B and C (1996โ€“1999, 1999โ€“2003) ๐Ÿงซ. He was a Visiting Scientist at UCLA (2001โ€“2003) ๐Ÿง , then joined Stanford University, where he advanced from Senior Research Scientist to Professor of Radiology (2003โ€“present) ๐Ÿ›๏ธ. His roles have spanned molecular imaging, translational research, and biomedical innovation across prestigious global institutions ๐Ÿ’ก๐Ÿ“ˆ.

Book Chapter ๐Ÿ“–

Prof. Dr. Ramasamy Paulmurugan has authored and co-authored over 27 book chapters, contributing to prestigious scientific volumes on molecular imaging, cancer biology, gene therapy, bioluminescence, and nanomedicine ๐Ÿ“–๐Ÿ”ฌ. His work spans publishers like Springer, Elsevier, Cambridge University Press, and World Scientific, reflecting his expertise in cutting-edge biomedical innovations ๐ŸŒ๐Ÿ“—. Topics include theranostics, glioblastoma resistance, protein-protein interaction imaging, microRNA therapy, and nanoparticle-based delivery systems for precision medicine ๐ŸŽฏ๐Ÿ’Š. His chapters are widely cited and used globally in advanced medical research, showcasing his status as a thought leader in translational and molecular medicine ๐Ÿงช๐ŸŒŸ.

Conference Presentations ๐ŸŒ๐ŸŽค

Prof. Dr. Ramasamy Paulmurugan has presented over 220 abstracts at leading international conferences spanning oncology, molecular imaging, nanomedicine, and gene therapy ๐Ÿงฌ๐Ÿง . His research has been showcased at AACR, WMIC, RSNA, IEEE, ASNR, and SPIE, reflecting sustained excellence and innovation across decades ๐Ÿ›๏ธ๐Ÿ”ฌ. Topics include molecular biosensors, microRNA therapy, nanoparticle delivery, ultrasound imaging, and cancer diagnostics. These presentations highlight collaborations with global experts and his role in pioneering translational research that bridges bench to bedside ๐Ÿงชโžก๏ธ๐Ÿฅ. His prolific and consistent contributions demonstrate global recognition and influence in biomedical innovation ๐ŸŒ๐Ÿ….

Research Focus ๐Ÿ”ฌ

Prof. Dr. Ramasamy Paulmuruganโ€™s research centers on molecular imaging, nanomedicine, and gene-based therapies to combat cancer and metabolic diseases like diabetes ๐Ÿง โš•๏ธ. He pioneers in vivo imaging of proteinโ€“protein interactions, miRNA delivery, and biosensor technologies for real-time monitoring of disease pathways ๐Ÿงฌ๐Ÿ“ธ. His innovations include split-luciferase systems, cell membrane-coated nanocarriers, and redox-sensitive signaling tools for precision therapeutics ๐ŸŽฏ๐Ÿงช. Bridging molecular biology with biomedical engineering, his translational research focuses on targeted drug delivery, noninvasive diagnostics, and theranostic nanoparticles, contributing significantly to personalized medicine and cancer theranostics ๐Ÿ’‰๐Ÿง ๐ŸŒ.

Publications ๐Ÿ“š

The fate and toxicity of Raman-active silica-gold nanoparticles in mice
Authors: A.S. Thakor, R. Luong, R. Paulmurugan, F.I. Lin, P. Kempen, C. Zavaleta, et al.
Journal: Science Translational Medicine, Vol. 3 (79), 79ra33

Noninvasive quantitative imaging of proteinโ€“protein interactions in living subjects
Authors: P. Ray, H. Pimenta, R. Paulmurugan, F. Berger, M.E. Phelps, M. Iyer, et al.
Journal: Proceedings of the National Academy of Sciences (PNAS), Vol. 99 (5), 3105โ€“3110

The emerging role of redox-sensitive Nrf2โ€“Keap1 pathway in diabetes
Authors: E. Bhakkiyalakshmi, D. Sireesh, P. Rajaguru, R. Paulmurugan, et al.
Journal: Pharmacological Research, Vol. 91, 104โ€“114

Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
Authors: T.Y. Wang, J.W. Choe, K. Pu, R. Devulapally, S. Bachawal, S. Machtaler, R. Paulmurugan, et al.
Journal: Journal of Controlled Release, Vol. 203, 99โ€“108

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging
Authors: M. Krishnan, J.M. Park, F. Cao, D. Wang, R. Paulmurugan, J.R. Tseng, et al.
Journal: FASEB Journal, Vol. 20 (1), 106โ€“108

Firefly luciferase enzyme fragment complementation for imaging in cells and living animals
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 77 (5), 1295โ€“1302

Molecular imaging of drug-modulated protein-protein interactions in living subjects
Authors: R. Paulmurugan, T.F. Massoud, J. Huang, S.S. Gambhir
Journal: Cancer Research, Vol. 64 (6), 2113โ€“2119

Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction
Authors: N. Jothikumar, K. Aparna, S. Kamatchiammal, R. Paulmurugan, et al.
Journal: Applied and Environmental Microbiology, Vol. 59 (8), 2558โ€“2562

Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 79 (6), 2346โ€“2353

Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics
Authors: R.J.C. Bose, R. Paulmurugan, J. Moon, S.H. Lee, H. Park
Journal: Drug Discovery Today, Vol. 23 (4), 891โ€“899

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Mr. Mohammed Amine Zitouni is an Algerian researcher specializing in polymer chemistry and macromolecular organic chemistry. He was born on August 31, 1985, in Sabra, Tlemcen, Algeria. Currently pursuing a Ph.D. in Polymer Chemistry at the University of Tlemcen, he holds a strong academic foundation with a Magister degree and a postgraduate diploma in chemistry. Mr. Zitouni has engaged in both national and international scientific activities, including participation in major conferences across Algeria and Russia. His research focuses on novel hydrogel synthesis, polymeric drug delivery systems, and chitosan-based materials.

Mr Mohammed Amine ZITOUNI, Laboratory of Research on macromolecules, Department of Chemistry, Science Faculty, University of Tlemcen, Algeria

Profile

ORCID

๐ŸŽ“ Education

Mr. Mohammed Amine Zitouni has a strong academic foundation in chemistry and life sciences ๐Ÿ“˜๐Ÿงช. He earned his Bachelor’s degree in Natural and Life Sciences in June 2003 ๐ŸŽ“๐ŸŒฟ. He then pursued a Postgraduate Diploma in Chemistry from the University of Tlemcen in September 2007 ๐Ÿงฌ๐Ÿซ. In December 2010, he obtained a Magister’s degree specializing in Macromolecular Organic Chemistry and Physical Chemistry โš—๏ธ๐Ÿ“š. Currently, he is working toward a Ph.D. in Polymer Chemistry at the University of Tlemcen, focusing on advanced polymeric materials for biomedical applications ๐Ÿ”ฌ๐Ÿ“–. His education reflects a clear commitment to scientific advancement.

๐ŸŒ Scientific Activities

Mr. Mohammed Amine Zitouni has actively participated in national and international scientific forums ๐ŸŒ. He presented at the 10th International Conference of the European Chitin Society in Russia and major Algerian conferences like the CIMPCโ€™17 in Tlemcen and the National Seminar on Polymers in Bejaรฏa ๐ŸŽค๐Ÿงช. With one year in the university tutoring program and four years of teaching LMD ST practical work, he contributes to student development ๐ŸŽ“๐Ÿง‘โ€๐Ÿซ. His research led to international publications on chitosan/PVA hydrogels in Advanced Materials Research and Annales pharmaceutiques franรงaises, focusing on novel drug delivery systems ๐Ÿ“„๐Ÿ’Š.

๐Ÿ’ป Skills

Mr. Mohammed Amine Zitouni is a multilingual researcher with strong communication and technical skills ๐ŸŒ๐Ÿง . He is a native Arabic speaker, and is proficient in reading and writing in French and English, including technical scientific English for academic and research purposes ๐Ÿ“˜๐Ÿ“š. His language skills allow him to effectively engage with international research communities and contribute to global scientific discourse ๐ŸŒโœ๏ธ. In addition, he possesses excellent computer skills, demonstrating a perfect command of software tools and digital platforms essential for scientific research, data analysis, and academic publishing ๐Ÿง‘โ€๐Ÿ’ป๐Ÿ“Š.

๐Ÿ”ฌ Research Focus

Mr. Mohammed Amine Zitouniโ€™s research focuses on the synthesis and characterization of biopolymer-based hydrogels for pharmaceutical applications ๐Ÿงช๐Ÿ’Š. He develops advanced drug delivery systems using crosslinked chitosan and polyvinyl alcohol (PVA), aiming to enhance controlled release of antibiotics such as chlorotetracycline hydrochloride ๐Ÿ”„๐Ÿงซ. His work explores the physicochemical interactions within hydrogels to optimize stability, biocompatibility, and drug release efficiency ๐Ÿ“ˆ๐Ÿงฌ. This research holds significant promise for medical treatments requiring sustained delivery mechanisms and aligns with sustainable, biodegradable material innovation ๐ŸŒฑ๐Ÿ”. His expertise contributes to the intersection of polymer science and biomedical engineering ๐Ÿง ๐Ÿฅ.

๐Ÿ“˜ Publications

Preparation and characterization of hydrogels based on Chitosan/polyvinyl alcohol blends
Journal: Advanced Materials Research
Focus: Synthesis and structural analysis of biocompatible hydrogels for advanced material applications.
๐Ÿงช๐Ÿ’ง

Release of Chlorotetracycline Hydrochloride From Novel Hydrogels Based On Crosslinked Chitosan And PVA
Journal: Annales Pharmaceutiques Franรงaises
Focus: Controlled drug release systems using crosslinked hydrogels for pharmaceutical applications.
๐Ÿ’Š๐Ÿงฌ๐Ÿ“—

Ann Kurian | Biomaterials | Best Researcher Award

Ms. Ann Kurian | Biomaterials | Best Researcher Award

Ann Anu Kurian is a biomedical researcher with over seven years of experience specializing in cellular biology and RNA-based gene delivery. She holds an MS in Biomedical Science from Morehouse School of Medicine and a BTech in Biotechnology from Lovely Professional University. Currently an Associate Researcher II and Lab Manager at the Icahn School of Medicine at Mount Sinai, her work focuses on cardiac and skeletal muscle regeneration using modified mRNA technologies. She has contributed to multiple peer-reviewed publications and has been recognized with several academic honors, including a Presidential Scholarship and research presentation awards.

Ms.Ann Kurian , Icahn school of medicine, United States.

Profile

GOOGLESCHOLAR

SCOPUS

๐ŸŽ“ Education

Ann Anu Kurian holds a Master of Science in Biomedical Science from Morehouse School of Medicine in Atlanta, Georgia, completed between August 2015 and May 2017. She also earned a Bachelor of Technology in Biotechnology from Lovely Professional University in India, where she studied from August 2009 to May 2013.

๐ŸŒŸ Experience

With over seven years of research experience, Ann currently serves as an Associate Researcher II and Research Lab Manager at the Icahn School of Medicine at Mount Sinai in New York. Since November 2023, she has been working in the Gregorio Laboratory, conducting research focused on understanding the components and molecular mechanisms that regulate actin architecture in cardiac and skeletal muscle during both normal development and disease. Prior to this, she held a similar role in the Zangi Laboratory from August 2017 to November 2023, where she led projects utilizing modified mRNA to improve cardiac outcomes post-injury and managed various aspects of laboratory operations. Her professional journey began in India at VWR International from January 2014 to August 2015, where she supported chemical projects, maintained product data in SAP, and enhanced product descriptions.

๐Ÿ… Awards and Honors

Ann has been recognized for her academic and research achievements, receiving a Presidential Scholarship from Morehouse School of Medicine in 2017. The same year, she earned a travel award to attend the Georgia Academy of Science annual meeting. She also presented her research at several prestigious conferences, including the Ninth AACR Conference on The Science of Cancer Health Disparities, the Curtis L. Parker Student Research Symposium, and the Georgia Academy of Science annual meeting.

๐Ÿ“–Skill

Ann is skilled in a wide range of technical and laboratory techniques. Her expertise includes molecular biology methods such as PCR, gel electrophoresis, cloning, RNA and DNA extraction, modified mRNA production, and LNP characterization. She is proficient in cell culture techniques, cardiomyocyte isolation, tissue sectioning, histological staining, and confocal microscopy. Her experience also includes data analysis, IVIS imaging, and statistical evaluation. She has strong capabilities in animal handling and laboratory management, including procurement, equipment maintenance, and regulatory compliance.

๐Ÿ”ฌ Research Focus

Ann’s research centers on cellular biology and RNA-based gene delivery systems, particularly in the context of cardiac and skeletal muscle biology. Her work has explored the use of modified mRNA technologies to induce gene expression for therapeutic regeneration following cardiac injury. Her contributions to the field are reflected in numerous peer-reviewed publications, addressing areas such as cardiomyocyte proliferation, ischemic injury, cardiac regeneration, and mRNA optimization.

๐Ÿ“˜ Publications

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, I Munir, T Mehmood, K Brown, โ€ฆ
Year: 2020
Journal: Circulation (Volume 141, Issue 15, Pages 1249โ€“1265)

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction
Authors: Y Hadas, AS Vincek, E Youssef, MM ลปak, E Chepurko, N Sultana, โ€ฆ
Year: 2020
Journal: Circulation (Volume 141, Issue 11, Pages 916โ€“930)

Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, MTK Sharkar, E Chepurko, L Zangi
Year: 2018
Journal: Molecular Therapy โ€“ Nucleic Acids (Volume 13, Pages 133โ€“143)

Optimization of 5โ€ฒ untranslated region of modified mRNA for use in cardiac or hepatic ischemic injury
Authors: N Sultana, Y Hadas, MTK Sharkar, K Kaur, A Magadum, AA Kurian, โ€ฆ
Year: 2020
Journal: Molecular Therapy Methods & Clinical Development (Volume 17, Pages 622โ€“633)

Direct reprogramming induces vascular regeneration post muscle ischemic injury
Authors: K Kaur, Y Hadas, AA Kurian, MM ลปak, J Yoo, A Mahmood, H Girard, โ€ฆ
Year: (Year not provided)
Journal: Molecular Therapy (Volume 29, Issue 10, Pages 3042โ€“3058)